Clinical Features	Time to Death		YEARS_TO_BIRTH		TUMOR_TISSUE_SITE		GENDER		RADIATION_THERAPY		HISTOLOGICAL_TYPE		RACE		ETHNICITY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
GTF2I	49 (41%)	71	0.52072	1	0.0024714	0.0395	0.65195	1	0.71364	1	0.0064267	0.0823	9.9999e-06	0.00064	0.53721	1	0.73585	1
HRAS	10 (8%)	110	0.70861	1	0.043176	0.345	0.68583	1	0.32309	0.97	1	1	0.00026	0.00555	1	1	1	1
CAPNS1	3 (2%)	117	0.70479	1	0.072217	0.42	1	1	0.11576	0.604	1	1	0.62284	1	1	1	1	1
TP53	4 (3%)	116	0.00010654	0.00341	0.43867	1	0.57875	1	0.61883	1	0.12263	0.604	0.03509	0.321	1	1	0.30252	0.97
ATRN	3 (2%)	117	0.57009	1	0.97294	1	0.50714	1	1	1	0.5509	1	0.44342	1	0.41277	1	1	1
NRAS	3 (2%)	117	0.42098	1	0.83211	1	0.50714	1	0.24391	0.97	0.28001	0.97	0.31016	0.97	0.067749	0.42	1	1
PLEKHG4B	3 (2%)	117	0.013794	0.147	0.067001	0.42	1	1	1	1	1	1	0.31181	0.97	NA	NA	1	1
UNC93B1	5 (4%)	115	0.65152	1	0.33335	0.97	1	1	0.67688	1	0.16105	0.736	0.38285	1	1	1	0.23575	0.97